← All indications
Sexually Transmitted Diseases
Diseases due to or propagated by sexual contact.
Subtype terms (2)
More specific conditions that are subtypes of Sexually Transmitted Diseases in the MeSH hierarchy.
- Sexually Transmitted Diseases, Bacterial
1 drug approved
- Sexually Transmitted Diseases, Viral
14 drugs (7 approved, 7 experimental)
Drugs by status
Phase 4 trials (7)
Phase 3 trials (12)
Phase 2 trials (5)
Phase 1 trials (1)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (16)
- Mayne Pharma
- Bausch Health Companies
- Jhpiego
- National Cancer Institute (NCI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Brown University
- Harvard University
- University of Washington
- Kenya Medical Research Institute
- Johns Hopkins University
- University of California, San Francisco
- City of San Francisco
- California HIV/AIDS Research Program
- Kenya National AIDS & STI Control Programme
- Amhara Public Health Institute
- Addis Continental Institute of Public Health
Organization Involved with Phase 3 Indications (16)
- Evofem Inc.
- GlaxoSmithKline
- Population Council
- Papua New Guinea Institute of Medical Research
- University of Melbourne
- University of Tampere
- Asociación Civil Impacta Salud y Educación, Peru
- University of Malawi
- Walter and Eliza Hall Institute of Medical Research
- University of Barcelona
- University of Western Australia
- Bill and Melinda Gates Foundation
- United States Agency for International Development
- Government of Finland
- Foundation for Paediatric Research, Finland
- Government of France
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (8)